2024

WHO Prequalifies First-Ever Chewable Albendazole, Advancing Global Fight Against Neglected Tropical Diseases

WHO Prequalifies First-Ever Chewable Albendazole, Advancing Global Fight Against Neglected Tropical Diseases In an achievement for global health, India-based Mepro Pharmaceuticals Pvt. Ltd. has received World Health Organization (WHO) prequalification for its generic chewable Albendazole 400 mg tablets, marking the first time this formulation has met the WHO’s rigorous standards. This pivotal

2024-09-10T09:18:29-04:00September 10th, 2024|
Go to Top